The resistance of stream periphyton to structural disturbance by increases in shear stress (simulating a spate) was investigated in a laboratory flow tank. We monitored loss of biomass from a filamentous community (dominated by Melosira varians) under four different levels of shear stress. In each case, any loss that was going to occur did so within 10 min for this community. In a second experiment, we tested the resistance of four different communities (two dominated by nonfilamentous diatoms and two dominated by filamentous green algae/diatoms) to increases in shear stress. Nine different levels of shear stress were used, ranging from 1‐ to 70‐fold higher than the conditions to which the communities were acclimated. All communities were 14 days old, but some differences in initial biomass occurred that influenced the degree of resistance independently of species composition. Overall, the nonfilamentous diatom communities were the most resistant, and the filamentous communities were the least resistant. The kinetics of the sloughing process varied among community types, with a community dominated by Melosira varians/Gom‐phonema parvulum losing 50% of its biomass with only a 3‐fold increase in shear stress. In contrast, a community dominated by the nonfilamentous diatoms Fragilaria vaucheriae/Cymbella minuta lost <50% of its biomass after a 70‐fold increase in shear stress. Shear stresses required for 50% loss of biomass for the different communities were as follows: 3.6 Newtons.m−2 for the Melosira varians/Gomphonema parvulum community, 10.0 N.m−2 for the Spirogyra sp./Gomphoneis her‐culeana/Ulothrix zonata community, 50.6 N.m−2 for the Fragilaria construens/Cymbella minuta/Ach‐nanthes minutissima community, and >90.0 N.m−2for the Fragilaria vaucheriae/Cymbella minuta community. These results show that spates without bedload movement can potentially have widely differing disturbance effects on periphyton loss among streams depending on the initial taxonomic composition of resident communities. These results have important implications for stream ecosystem analysis and modeling.

BackgroundHigh levels of ketone bodies are associated with improved survival as observed with regular exercise, caloric restriction, and—most recently—treatment with sodium–glucose linked transporter 2 inhibitor antidiabetic drugs. In heart failure, indices of ketone body metabolism are upregulated, which may improve energy efficiency and increase blood flow in skeletal muscle and the kidneys. Nevertheless, it is uncertain how ketone bodies affect myocardial glucose uptake and blood flow in humans. Our study was therefore designed to test whether ketone body administration in humans reduces myocardial glucose uptake (MGU) and increases myocardial blood flow.Methods and ResultsEight healthy subjects, median aged 60 were randomly studied twice: (1) During 390 minutes infusion of Na‐3‐hydroxybutyrate (KETONE) or (2) during 390 minutes infusion of saline (SALINE), together with a concomitant low‐dose hyperinsulinemic–euglycemic clamp to inhibit endogenous ketogenesis. Myocardial blood flow was measured by 15O‐H2O positron emission tomography/computed tomography, myocardial fatty acid metabolism by 11C‐palmitate positron emission tomography/computed tomography and MGU by 18F‐fluorodeoxyglucose positron emission tomography/computed tomography. Similar euglycemia, hyperinsulinemia, and suppressed free fatty acids levels were recorded on both study days; Na‐3‐hydroxybutyrate infusion increased circulating Na‐3‐hydroxybutyrate levels from zero to 3.8±0.5 mmol/L. MGU was halved by hyperketonemia (MGU [nmol/g per minute]: 304±97 [SALINE] versus 156±62 [KETONE], P<0.01), whereas no effects were observed on palmitate uptake oxidation or esterification. Hyperketonemia increased heart rate by ≈25% and myocardial blood flow by 75%.ConclusionsKetone bodies displace MGU and increase myocardial blood flow in healthy humans; these novel observations suggest that ketone bodies are important cardiac fuels and vasodilators, which may have therapeutic potentials.

During acute inflammation, 3OHB has potent anticatabolic actions in muscle and at the whole-body level; in muscle, reduction of protein breakdown overrides inhibition of synthesis. This trial was registered at clinicaltrials.gov as NCT01752348.

No abstract

BackgroundLipolysis is accelerated during the acute phase of inflammation, a process being regulated by pro-inflammatory cytokines (e.g. TNF-α), stress-hormones, and insulin. The intracellular mechanisms remain elusive and we therefore measured pro- and anti-lipolytic signaling pathways in adipocytes after in vivo endotoxin exposure.MethodsEight healthy, lean, male subjects were investigated using a randomized cross over trial with two interventions: i) bolus injection of saline (Placebo) and ii) bolus injection of lipopolysaccharide endotoxin (LPS). A 3H-palmitate tracer was used to measure palmitate rate of appearance (Rapalmitate) and indirect calorimetry was performed to measure energy expenditures and lipid oxidation rates. A subcutaneous abdominal fat biopsy was obtained during both interventions and subjected to western blotting and qPCR quantifications.ResultsLPS caused a mean increase in serum free fatty acids (FFA) concentrations of 90% (CI-95%: 37–142, p = 0.005), a median increase in Rapalmitate of 117% (CI-95%: 77–166, p<0.001), a mean increase in lipid oxidation of 49% (CI-95%: 1–96, p = 0.047), and a median increase in energy expenditure of 28% (CI-95%: 16–42, p = 0.001) compared with Placebo. These effects were associated with increased phosphorylation of hormone sensitive lipase (pHSL) at ser650 in adipose tissue (p = 0.03), a trend towards elevated pHSL at ser552 (p = 0.09) and cAMP-dependent protein kinase A (PKA) phosphorylation of perilipin 1 (PLIN1) (p = 0.09). Phosphatase and tensin homolog (PTEN) also tended to increase (p = 0.08) while phosphorylation of Akt at Thr308 tended to decrease (p = 0.09) during LPS compared with Placebo. There was no difference between protein or mRNA expression of ATGL, G0S2, and CGI-58.ConclusionLPS stimulated lipolysis in adipose tissue and is associated with increased pHSL and signs of increased PLIN1 phosphorylation combined with a trend toward decreased insulin signaling. The combination of these mechanisms appear to be the driving forces behind the increased lipolysis observed in the early stages of acute inflammation and sepsis.Trial RegistrationClinicalTrials.gov NCT01705782